BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 48646)

  • 1. Letter: 1-18 Corticotrophin and allergy to tetracosactrin-depot.
    Brombacher PJ; Maesen FP; Gijzen AH
    Lancet; 1975 Feb; 1(7904):456. PubMed ID: 48646
    [No Abstract]   [Full Text] [Related]  

  • 2. [Adverse effects of synthetic ACTH (tetracosactide-Zn)--asthmatic attack and shock-report of 2 cases].
    Kawai M; Maekawa N
    Nihon Kyobu Shikkan Gakkai Zasshi; 1975 Nov; 13(11):663-70. PubMed ID: 176495
    [No Abstract]   [Full Text] [Related]  

  • 3. Corticotrophin and tetracosactrin depot-self-administered for the treatment of eczema.
    Munro DD
    Br J Dermatol; 1976 Mar; 94 suppl 12():135-8. PubMed ID: 178340
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Letter: Allergic reactions to tetracosactrin.
    Mohr PD
    Br Med J; 1975 Oct; 4(5989):162. PubMed ID: 172182
    [No Abstract]   [Full Text] [Related]  

  • 5. Assessment of long-acting synthetic corticotrophin in hypersensitive asthmatics and normal subjects.
    el-Shaboury AH
    Br Med J; 1968 Sep; 3(5619):653-5. PubMed ID: 4299775
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Severe bronchial obstruction as a reaction to the administration of the tetracosactides depot-Cortrosyn and depot-Synacthen].
    Roldaan AC; de Jong C
    Ned Tijdschr Geneeskd; 1981 Feb; 125(8):321-3. PubMed ID: 6261167
    [No Abstract]   [Full Text] [Related]  

  • 7. [Tetracosactide (Synacthen Depot) in patients with multiple sclerosis].
    Kanić M; Sepcić J
    Lijec Vjesn; 1992; 114(5-8):134-6. PubMed ID: 1343045
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adverse reactions to Zn1-24 ACTH therapy associated with specific cellular immunity.
    Glass D; Roffe L; Maini RN; Wraith DG; Nuki G
    Clin Exp Immunol; 1975 Apr; 20(1):55-63. PubMed ID: 173487
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Allergy to tetracosactrin-depot.
    Partiarca G
    Lancet; 1971 Jan; 1(7690):138. PubMed ID: 4099629
    [No Abstract]   [Full Text] [Related]  

  • 10. [Experiences with depot-ACTH (Tetracosactide) in bronchial obstruction].
    Kropp R
    Fortschr Med; 1976 Mar; 94(7):395-8. PubMed ID: 184022
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Measurement of the adrenal cortex reserve using depot beta 1-24-corticotrophin. II---in thyroid diseases.
    Galvão-Teles A
    Acta Med Port; 1979; 1(3):315-24. PubMed ID: 233190
    [No Abstract]   [Full Text] [Related]  

  • 12. Hypersensitivity to different ACTH peptides.
    Forssman O; Mulder J
    Acta Med Scand; 1973 Jun; 193(6):557-9. PubMed ID: 4352856
    [No Abstract]   [Full Text] [Related]  

  • 13. Evaluation and management of corticotropin allergy.
    Lee TM; Grammer LC; Shaughnessy MA; Patterson R
    J Allergy Clin Immunol; 1987 Jun; 79(6):964-8. PubMed ID: 3034995
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effect of intravenous hydrocortisone and intramuscular ACTH on spirometric indicators in patients with partially reversible bronchial stenosis].
    Müller J; Radomyski A; Vertun-Baranowska B; Styszewsko H
    Pneumonol Pol; 1987 Jan; 55(1):26-33. PubMed ID: 3035512
    [No Abstract]   [Full Text] [Related]  

  • 15. [Spastic flexion disorders: clinical and metabolic problems observed during treatment with zinc tetracosactide].
    Cret L; David M; Macabéo V; Frédérich A; Jeune M
    Pediatrie; 1976; 31(1):33-48. PubMed ID: 184427
    [No Abstract]   [Full Text] [Related]  

  • 16. Tetracosactrin for the management of asthmatic patients after long-term corticosteroids.
    Hugh-Jones P; Pearson RS; Booth M
    Thorax; 1975 Aug; 30(4):426-9. PubMed ID: 170703
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Use of Cortrosyn Depot in dermatology].
    Aussems J
    Brux Med; 1976 Jan; 56(1):15-20. PubMed ID: 175889
    [No Abstract]   [Full Text] [Related]  

  • 18. [Long-term Cortrosyn-depot therapy of steroid-dependent patients suffering from bronchial asthma].
    Rott Z; Fajt E; Tóth S; Hammer I; Nagy G
    Orv Hetil; 1983 Jul; 124(31):1883-6. PubMed ID: 6314223
    [No Abstract]   [Full Text] [Related]  

  • 19. A synthetic polypeptide--beta 1-24 corticotropin--in the depot form. II. Clinical efficacy of intermittent therapy in asthmatic patients.
    Benos SA; Koutsoukos A; Sotirakis I; Pavlatos FC
    Acta Allergol; 1969 Sep; 24(3):178-86. PubMed ID: 4314190
    [No Abstract]   [Full Text] [Related]  

  • 20. [Fatal complication of intravenous administration of synthetic adrenocorticotrophin].
    Müller M; Fehm HL; Homoki J; Teller WM
    Dtsch Med Wochenschr; 1982 Sep; 107(36):1353-6. PubMed ID: 6288339
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.